|
West North Central U.S. Biotech News. Service for global professionals. Constantly updated news and information about West North Central U.S. Biotech.
Latest West North Central U.S. Biotech News
- U.S. Chamber official likes Kansas' job prospects 24 Nov 2009 06:51 GMT
... A U.S. Chamber of Commerce official leading a nationwide ... official leading a nationwide job-creation initiative says Kansas is well positioned to benefit from emerging fields, such ... on that scale, and I think the biotechnology and nanotechnology and other areas are certainly ...
- Five Outstanding NCKU Alumni Honored With 2009 NCKU Outstanding Alumni Award 24 Nov 2009 03:50 GMT
... their respect fields either in the academia, industry, or business, I invite you to come ... International Writers' Workshop at the University of Iowa in 1965. From 1965 to 1993 he taught Chinese ... Management, Social Sciences, Medicine, and Bioscience & Biotechnology. NCKU currently offers 40 undergraduate programs (excluding ...
- Calix plans $100 million IPO 24 Nov 2009 01:03 GMT
... Calix, which makes makes optical networking technology for ... County IPO since January 2007, when Petaluma biotech startup Oculus Innovative Sciences went public. Calix ... Cerent Corp. It also has facilities in Minnesota and Massachusetts. The company doesn’t disclose employment data, ...
- BioCee provides homes for good germs Tech Tuesday 24 Nov 2009 07:32 GMT
... MINNEAPOLIS — BioCee Inc. calls itself an industrial biotech company. But co-founder and chief technology officer ... start-up, spun off from the University of Minnesota, is developing thin-layer coatings that provide microorganisms like ...
- Proteon Initiates Second Phase 1/2 Clinical Study Of PRT-201 In Hemodialysis Patients 24 Nov 2009 09:55 GMT
... Proteon Therapeutics, Inc., has initiated a Phase 1/2 ... years experience in the medical products and biotechnology fields, where he has held Chief Executive ... Waltham, Mass., and has research facilities in Kansas City, Mo. Source: Proteon Therapeutics (Hover over the ...
- Product Performance to Fuel 2010 Share Gains for DuPont Seed Business 23 Nov 2009 14:40 GMT
... increase its position in the high value biotech corn market. Just two years since biotech ... pay off for growers.” , a DuPont business, is the world's leading source of customized ... oilseed processors. With headquarters in Des Moines, Iowa, Pioneer provides access to advanced plant genetics in ...
- Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 23 Nov 2009 11:30 GMT
... SOUTH SAN FRANCISCO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- ... received his Ph.D. from the University of Kansas and his B.Sc. from the University of Glasgow, Scotland. ... trial results; the competitive environment in the biotechnology industry; and whether the Anesiva can successfully ...
- Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed M 23 Nov 2009 11:33 GMT
... Anesiva Announces Prospective Board Members To Be Appointed ... received his Ph.D. from the University of Kansas and his B.Sc. from the University of Glasgow, Scotland. ... trial results; the competitive environment in the biotechnology industry; and whether the Anesiva can successfully ...
- Ception Therapeutics and Cephalon Provide Initial Results of a... 23 Nov 2009 13:33 GMT
... MALVERN, Pa. and FRAZER, Pa., Nov. 23 /PRNewswire-FirstCall/ ... Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon has a growing presence in Europe, the ... economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more ...
- Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 23 Nov 2009 14:01 GMT
... Ception Therapeutics and Cephalon Provide Initial Results of ... Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon has a growing presence in Europe, the ... economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more ...
- Pharma Companies Navigate Sunshine Act and Doctor Payments, According to Cutting Edge Information 23 Nov 2009 14:30 GMT
... RESEARCH TRIANGLE PARK, NC -- (MARKET WIRE) -- ... -- Proposed legislation would require every pharmaceutical, biotech and medical device company to report all ... required drug companies to report payments since Minnesota passed the first such law in 1993. Today, ...
- Pharma Companies Navigate Sunshine Act and Doctor Payments, According to Cutting Edge Information 23 Nov 2009 15:16 GMT
... Pharma Companies Navigate Sunshine Act and Doctor Payments, ... Information Proposed legislation would require every pharmaceutical, biotech and medical device company to report all ... required drug companies to report payments since Minnesota passed the first such law in 1993. Today, ...
- Calix plans $100 million IPO 23 Nov 2009 20:36 GMT
... Carl Russo, shown here in 2005, is CEO of ... first IPO in Sonoma County since Petaluma biotech company, Oculus Innovative Sciences, opened on the ... Cerent Corp. It also has facilities in Minnesota and Massachusetts. The company doesn’t disclose employment data, ...
- YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 23 Nov 2009 22:30 GMT
... MISSISSAUGA, ON, Nov. 23 /PRNewswire-FirstCall/ - YM BioSciences ... being conducted at Mayo Clinic in Rochester, Minnesota. A proposal to merge Cytopia into YM has ... be important." Cytopia Ltd is an Australian biotechnology company focused on the discovery and development ...
- YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY 23 Nov 2009 22:33 GMT
... YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL ... being conducted at Mayo Clinic in Rochester, Minnesota. A proposal to merge Cytopia into YM has ... be important." Cytopia Ltd is an Australian biotechnology company focused on the discovery and development ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
| |
|